Sunday, December 28, 2025
ADVT 
National

No unexpected effects from COVID-19 shots so far

Darpan News Desk The Canadian Press, 08 Jan, 2021 06:26 PM
  • No unexpected effects from COVID-19 shots so far

Health Canada has no reports of unexpected side-effects from patients vaccinated against COVID-19 thus far.

"There haven't been any serious adverse events, or even the mild and moderate adverse events, that have been out of line or different than what we've seen in the clinical trials," Dr. Supriya Sharma said in an interview with The Canadian Press Friday.

Sharma, Health Canada's chief medical adviser, is overseeing the vaccine review process.

She said experts look for two things when reviewing data after vaccines are given. The first is whether anything happens that was not observed during the clinical trials, and the second is whether the side-effects that were documented during the trials are more severe or greater in number than what the trials saw.

The answer to both questions in Canada so far is no, said Sharma.

"It seems that the clinical trials are pretty representative," she said.

The most common side-effects from the vaccines are short-term fever, pain at the injection site, headache and fatigue. Most subside within 24 hours.

Health Canada approved two vaccines for COVID-19 in December, including one from Pfizer and BioNTech and a second from Moderna.

Vaccinations began Dec. 14, and data aggregated by University of Saskatchewan student Noah Little shows about 230,000 doses have been given so far. Most of the first doses went to front-line hospital staff and long-term care workers and a smaller number of long-term care residents.

Vaccines began reaching some First Nations and northern territories this week.

Health Canada continues to review data from two other vaccine developers, AstraZeneca and Johnson & Johnson, but is still awaiting more data from the companies. Sharma said she can't say when Health Canada would be ready to make a decision about either one.

Both companies are expected to complete Phase 3 clinical trials in the United States this month.

MORE National ARTICLES

BoC to address gap in inflation beliefs

BoC to address gap in inflation beliefs
A senior Bank of Canada official says that many Canadians believe that official inflation measures don't reflect the rising costs they face.

BoC to address gap in inflation beliefs

Poll shows worries about COVID-19 vaccine

Poll shows worries about COVID-19 vaccine
A new Statistics Canada survey suggests that while the vast majority of Canadians would get a COVID-19 vaccine if and when it becomes available, more than one in 10 likely would not.

Poll shows worries about COVID-19 vaccine

Feds give $82.5M for Indigenous mental health

Feds give $82.5M for Indigenous mental health
The federal government is pledging $82.5 million to improve access and address growing demand for mental health services in Indigenous communities during the COVID-19 pandemic.

Feds give $82.5M for Indigenous mental health

Quebecois 'Brooklyn Nine-Nine' faces backlash

Quebecois 'Brooklyn Nine-Nine' faces backlash
Quebec's French-language adaptation of the popular American police comedy, "Brooklyn Nine-Nine," is already taking heat before the first episode airs — from one of the actors in the original series.

Quebecois 'Brooklyn Nine-Nine' faces backlash

Lawsuit filed in Icefield bus crash

Lawsuit filed in Icefield bus crash
A class-action lawsuit alleging the defendants acted recklessly and unreasonably has been filed against the operators of a tour bus involved in a fatal rollover at Jasper National Park's Columbia Icefield.

Lawsuit filed in Icefield bus crash

Trudeau Liberals come out ahead in new survey

Trudeau Liberals come out ahead in new survey
 A new poll suggests Prime Minister Justin Trudeau would be well placed to fight an election this fall, seen as the leader best able to care for Canadians during the COVID-19 pandemic and to get the economy back on its feet.

Trudeau Liberals come out ahead in new survey